Topics

Novartis International AG: Novartis to highlight extensive long-term safety and efficacy data of Aimovig across the spectrum of migraine at AAN

16:41 EDT 2 May 2019 | FinanzNachrichten

Novartis International AG / Novartis to highlight extensive long-term safety and efficacy data of Aimovig across the spectrum of migraine at AAN . Processed and transmitted by West Corporation. The...

Original Article: Novartis International AG: Novartis to highlight extensive long-term safety and efficacy data of Aimovig across the spectrum of migraine at AAN

NEXT ARTICLE

More From BioPortfolio on "Novartis International AG: Novartis to highlight extensive long-term safety and efficacy data of Aimovig across the spectrum of migraine at AAN"

Quick Search

Relevant Topics

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...